Suppr超能文献

[术前门静脉栓塞:诱导健侧肝脏肥大及增加肝切除适应证的有效手段]

[Preoperative portal embolization: an effective means for inducing hypertrophy of the healthy liver and increasing indications for hepatic resection].

作者信息

Roche A, Lasser P, de Baère T, Elias D

机构信息

Service de radiologie interventionnelle, institut Gustave-Roussy, Villejuif, France.

出版信息

Chirurgie. 1998 Feb;123(1):67-72; discussion 73. doi: 10.1016/s0001-4001(98)80041-x.

Abstract

AIM OF THE STUDY

The aim of the preoperative portal embolization is a redistribution of the portal venous blood flow in an attempt to induce hypertrophy of the future remnant liver in order to perform a curative liver resection.

MATERIAL AND METHODS

Preoperative portal embolization was performed in a group of 43 patients. The volumetric ratio (future remnant liver/total liver-tumor) was 20%. Liver metastases were present in 40 patients and primary liver tumor in three. Twenty-four patients had received chemotherapy prior to the preoperative portal embolization. Required operative procedures were right hepatectomy (n = 15), right hepatectomy extended to the segment IV (n = 24) or atypical resection (n = 4). Preoperative portal embolization was performed under percutaneous transhepatic approach with a Blue Histoacryl and Lipiodol Ultra Fluide mixture. Liver volumetric measurements were obtained with 3D color encoded computed tomography, before portal embolization and before surgery.

RESULTS

Hypertrophy of the future remnant liver was 83 +/- 58% after a mean 32-day interval between portal embolization and surgery. The tolerance of portal embolization was excellent. Thirty-six hepatectomies were performed as initially planned; seven were cancelled for emergence of metastases (distant in six patients and intrahepatic in one).

CONCLUSION

Pre-operative portal embolization is a safe and effective procedure which increases the possibilities of curative resection in the liver tumors.

摘要

研究目的

术前门静脉栓塞的目的是重新分配门静脉血流,试图诱导未来残余肝脏肥大,以便进行根治性肝切除术。

材料与方法

对43例患者进行了术前门静脉栓塞。体积比(未来残余肝脏/全肝-肿瘤)为20%。40例患者存在肝转移,3例为原发性肝癌。24例患者在术前门静脉栓塞前接受过化疗。所需的手术方式为右肝切除术(n = 15)、扩展至IV段的右肝切除术(n = 24)或非典型切除术(n = 4)。术前门静脉栓塞采用经皮经肝途径,使用蓝色组织黏合剂和超液态碘油混合物进行。在门静脉栓塞前和手术前,通过三维彩色编码计算机断层扫描获得肝脏体积测量值。

结果

门静脉栓塞与手术之间平均间隔32天后,未来残余肝脏的肥大率为83±58%。门静脉栓塞的耐受性良好。36例肝切除术按原计划进行;7例因出现转移(6例为远处转移,1例为肝内转移)而取消。

结论

术前门静脉栓塞是一种安全有效的手术,可增加肝肿瘤根治性切除的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验